DXB 1.28% 38.5¢ dimerix limited

Recce Pharmaceuticals (ASX:RCE) gains ethics approval to start burns study, page-11

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    It’s already cross- promoted at the top of our thread page with an automatic insert of your email address to click on a button to learn more about the stock. It sounds interesting in early stage development of treating infected burns, & those who are interested will read & good luck to RCE.

    We don’t need a new thread that is against TOUs as well (cross promotion). I’ve just reported it as well, out of principle (the thread not the paid advertising by RCE).


 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.